公司概覽
業務類別 Biotechnology
業務概覽 VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.
公司地址 11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121
電話號碼 +1 858 224-1000
傳真號碼 --
公司網頁 https://www.organovo.com
員工數量 15
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Keith Murphy Executive Chairman of the Board and Principal Executive Officer 美元 726.67K 03/11/2025
Mr. Norman Staskey President, Principal Accounting Officer and Chief Financial Officer 美元 20.93K 03/11/2025
Mr. Tony Lialin Chief Commercial Officer -- 14/08/2025
 
董事會成員
董事會 職務 更新日期
Mr. Adam K. Stern Independent Director 03/11/2025
Mr. Keith Murphy Executive Chairman of the Board and Principal Executive Officer 03/11/2025
Mr. Douglas Jay Cohen Lead Independent Director 03/11/2025
Mr. David Gobel Independent Director 03/11/2025
Ms. Alison Tjosvold Milhous Independent Director 03/11/2025
 
所屬ETF (更新日期: 09/05/2026 04:32)
代號 名稱 佔比% 持有日期
GRXGabelli Health & Wellness0.12%31/12/2025
ITOTiShares Core S&P Total US Stock Mkt ETF<0.000001%06/03/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.